ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...

“As the first oral penem approved in the U.S., ORLYNVAH™ offers an excellent alternative treatment option for appropriate patients in the underserved uUTI market. With FDA approval and a ...

“As the first oral penem approved in the U.S., ORLYNVAH™ offers an excellent alternative treatment option for appropriate patients in the underserved uUTI market. With FDA approval and a clear ...

with the increasing appreciation for the role of the oral microbiome in both oral and systemic health,” said Sue Lynch, PhD, professor in the School of Medicine and director of the BCMM. “In addition ...

Education programmes for healthcare professionals involved in the management of atrial fibrillation can increase adherence to guidelines and improve patient safety, according to a recent trial.

Novel HIV treatment options that allow for less frequent oral dosing have the potential to help support adherence, and address stigma faced by some individuals taking daily oral therapy,” said Dr.